18-3879687-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004746.4(DLGAP1):āc.382G>Cā(p.Val128Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,607,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004746.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLGAP1 | NM_004746.4 | c.382G>C | p.Val128Leu | missense_variant | 4/13 | ENST00000315677.8 | NP_004737.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLGAP1 | ENST00000315677.8 | c.382G>C | p.Val128Leu | missense_variant | 4/13 | 5 | NM_004746.4 | ENSP00000316377.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000410 AC: 10AN: 243722Hom.: 0 AF XY: 0.0000453 AC XY: 6AN XY: 132462
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1455094Hom.: 0 Cov.: 31 AF XY: 0.00000967 AC XY: 7AN XY: 724216
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2024 | The c.382G>C (p.V128L) alteration is located in exon 4 (coding exon 1) of the DLGAP1 gene. This alteration results from a G to C substitution at nucleotide position 382, causing the valine (V) at amino acid position 128 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at